12:00 AM
 | 
Jan 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

Amorfix, JSW Lifesciences GmbH deal

CRO JSW Lifesciences signed a letter of intent for an exclusive, worldwide license to use Amorfix's Amorfix Aggregated Abeta Assay (A4)...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >